Sarcoma and Nosebleed

Summary:

Nosebleed is found among people with Sarcoma, especially for people who are male, 60+ old.

The study analyzes which people have Nosebleed with Sarcoma. It is created by eHealthMe based on reports of 26 people who have Sarcoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Sarcoma?

Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues) is found to be associated with 138 drugs and 308 conditions by eHealthMe. Check the latest studies of Sarcoma.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,080 drugs and 3,093 conditions by eHealthMe. Check the latest studies of Nosebleed.



On Jul, 23, 2026

26 people who have Sarcoma and Nosebleed are studied.

Would you have Nosebleed when you have Sarcoma?

Gender of people who have Sarcoma and experienced Nosebleed *:

  • female: 41.67 %
  • male: 58.33 %

Age of people who have Sarcoma and experienced Nosebleed *:

  • 0-1: 0.0 %
  • 2-9: 14.29 %
  • 10-19: 19.05 %
  • 20-29: 4.76 %
  • 30-39: 9.52 %
  • 40-49: 0.0 %
  • 50-59: 14.29 %
  • 60+: 38.1 %

Common co-existing conditions for these people *:

  1. Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 3 people, 11.54%
  2. Sarcoma Metastatic (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues spreads to other parts): 1 person, 3.85%
  3. Neoplasm Malignant (cancer tumour): 1 person, 3.85%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 3.85%
  5. Liposarcoma (a cancer tumour that arises in fat cells in deep soft tissue): 1 person, 3.85%
  6. Breast Cancer Female: 1 person, 3.85%
  7. Abdominal Pain: 1 person, 3.85%

Common drugs taken by these people *:

  1. Ifosfamide: 6 people, 23.08%
  2. Votrient: 6 people, 23.08%
  3. Aspirin: 6 people, 23.08%
  4. Ondansetron: 5 people, 19.23%
  5. Reglan: 4 people, 15.38%
  6. Alavert: 4 people, 15.38%
  7. Decadron: 4 people, 15.38%
  8. Lidocaine: 4 people, 15.38%
  9. Mesna: 4 people, 15.38%
  10. Omeprazole: 4 people, 15.38%

Common symptoms for these people *:

  1. Febrile Neutropenia (fever with reduced white blood cells): 6 people, 23.08%
  2. Fatigue (feeling of tiredness): 6 people, 23.08%
  3. Diarrhea: 6 people, 23.08%
  4. Ingrowing Nail: 4 people, 15.38%
  5. Stomatitis (inflammation of mucous membrane of mouth): 4 people, 15.38%
  6. Gingival Bleeding (bleeding gums): 4 people, 15.38%
  7. Wound Dehiscence (a surgical incision reopens either internally or externally): 4 people, 15.38%
  8. Mucosal Inflammation (infection of mucous membrane): 4 people, 15.38%
  9. Postoperative Wound Complication: 4 people, 15.38%
  10. Dry Mouth: 3 people, 11.54%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Nosebleed:

All the conditions that are associated with Nosebleed:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Nosebleed and Sarcoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: